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Abstract:  The enantioselective Taniaphos·silver fluoride-catalyzed enantioselective 1,3-dipolar 
cycloaddition using 2,2-dimethoxyacetaldehyde derived imino esters and maleimides is described. 
The employment of this complex allows the reaction in the absence of an extra base giving high 
yields and ee of the corresponding endo-cycloadducts. Calculations performed at B3LYP/6-
31G*&LANL2DZ level of theory predicted the expected absolute stereochemistry for both BINAP 
and Taniaphos·silver fluoride-mediated cycloadditions, as well as the enantioselectiviy and mild 
conditions of the reaction. 
 
Keywords: dipolar cycloaddition · taniaphos · silver(I) ·  enantioselective · 2,2-
dimethoxyacetaldehyde·azomethine ylides 
 
Dedicated to Prof. Gary Posner on the occasion of his retirement 
 
 
1. Introduction 
 
1,3-Dipolar cycloadditions (1,3-DCs)1 involving stabilized azomethine ylides are fascinating 
reactions2 due to the high control of the regio-, diastereo- and enantioselection. However, they have 
limitations concerning the structure of the dipole precursor. Compared to arylideneamino esters, 
alkylideneamino esters are not found to be appropriate ylide precursors in conventional 
enantioselective metal-catalyzed 1,3-DC. In many cases In many cases, the corresponding imines 
are not formed quantitatively or even the stereoselectivity of the 1,3-DCs using different 
dipolarophiles is not very high. Regarding the asymmetric version of this 1,3-DC3 many examples 
have been reported employing chiral Lewis acids (mainly metal complexes) and organocatalysts. 
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The resulting enantiomerically enriched prolines or pyrrolidines endo-1 normally incorporate an 
aryl or heteroaryl substituent but rarely extend to cases that have an aliphatic group at the 5-
position. Waters’ group developed recently a 2-aza-Cope-[3+2] dipolar cycloaddition preparing α-
allylproline derivatives with different substituents at the 5-position of the heterocyclic ring.4 The 
interest of this objective is to gain a new functionalization on the pyrrolidine ring ready to be 
transformed into other different functionalities. 
Following this idea, we recently reported the (S)-BINAP 4·Ag2CO3-catalyzed 
enantioselective 1,3-DC using ethyl glyoxylate for the preparation of diastero- and enantiomerically 
enriched endo-pyrrolidines 2 with a 2,5-cis-arrangement. Because of the instability of the imino 
esters derived of ethyl glyoxylate this process was performed in a multicomponent fashion allowing 
the introduction of an ester group at the 5-position. In this case, use of a base was not necessary as 
the chiral complex behaved as a bifunctional catalyst.5 The incorporation of a 2,2-dimethoxymethyl 
group at the 5-position (compound endo-3) was reported in a previous non asymmetric silver-
catalyzed multicomponent reaction between 2,2-dimethoxyacetaldehyde, α-amino esters and 
dipolarohiles in the presence of triethylamine.6 
 
 
    
In this work we describe the introduction of the 2,2-dimethoxymethyl group at the 5-
position of the final proline derivative employing the imino ester derived from 2,2-
dimethoxyacetaldehyde and the corresponding amino ester, through an enantioselective process 
catalyzed by chiral silver complexes using chiral phosphorous ligands.7 
 
 
2. Results and discussion 
 
The synthesis of enantiomerically enriched prolinates endo-3 was initially attempted using 
the best reaction conditions reported for the multicomponent synthesis of chiral endo-2 
cycloadducts,5 using phenyl alanine ethyl ester, N-methylmaleimide (NMM, 5a), 2,2-
dimethoxyacetaldehyde and 5 mol% of the catalyst (S)-BINAP 4·Ag2CO3. All these components 
were mixed and, after 1 d at room temperature, a very complex reaction crude was observed (1H 
NMR). Unlike ethyl glyoxylate, 2,2-dimethoxyacetaldehyde was able to form, almost 
quantitatively, stable imino esters 6 which  could be employed in a two-component cycloaddition.  
Thus, as a model reaction glycine derived imino ester 6a and N-methylmaleimide (NMM, 5a) were 
catalyzed by a complex formed by 5 mol% of a chiral ligand and 5 mol% of a silver(I) salt (Scheme 
1). Initially, (S)-BINAP 4a·AgTfa (Tfa = trifuoroacetate) as chiral catalyst was chosen.8,9 In all of 
these cases, the chiral catalyst was formed in situ by mixing the corresponding chiral ligand with 
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the silver salt in toluene stirring the mixture for 30 min at room temperature (25 ºC). The evaluation 
of the importance of the organic base (5 mol%) in the reaction was done first. Cycloadduct 7aa was 
obtained with high conversions and with 60% ee independently of the added base (triethylamine or 
DIPEA, Table 1, entries 1 and 2). However, a 64% ee was determined when the reaction was 
performed under identical conditions but in the absence of base (Table 1, entry 3). Looking for 
basic silver salts, carbonate, acetate, and benzoate were assayed (Table 1, entries 4-6). Silver 
carbonate was the most appropriate salt for the enantioselective multicomponent 1,3-DC involving 
ethyl glyoxylate,5 nevertheless no improvement was observed in the enantiomeric excess of endo-
7aa (Table 1, entry 4). AgOBz and AgOAc afforded endo-7aa with 65% and 60% ee, respectively 
(Table 1, entries 5 and 6). (S)-BINAP 4a·AgF10 was more efficient at room temperature rather than 
at -20 ºC, affording product endo-7aa with 72% ee (Table 1, entries 7 and 8).  
The ligand was the next parameter to be changed. Thus, the small variation introduced with 
(S)-Tol-BINAP 4b gave the same results as (S)-Binap (Table 1, entry 9). Modification of the bite 
angle using (S)-H8-BINAP 8 or (S)-Segphos 9 resulted in lower enantioselection in cycloadduct 
7aa (Table 1, entries 10 and 11). Widely used chiral phosphoramidites 10-14 were tested together 
with silver fluoride. Despite high conversions, the results of the corresponding enantioselectivities 
were very disappointing. (S)-Monophos 10 and (Sa,R,R)-phosphoramidites 11a and 11b11,12 induced 
up to 26% ee (Table 1, entries 12-14) and almost racemic endo-7aa was obtained using 
phosphoramidite (S)-13 (Table 1, entry 16). H8-Phosphoramidite 12 furnished comparable results to 
those obtained in the same reaction run with (S)-BINAP 4a·AgTfa (Table 1, compare entries 3 and 
15). Taddol derived phosphoramidite 14 afforded a crude endo-7aa product (60% ee) contaminated 
with some endo/exo diastereoisomers (Table 1, entry 17). Bisphosphanes 15, 16 and 17 were 
allowed to form the corresponding chiral complex with AgF at room temperature and next 
evaluated in the model 1,3-DC shown in Scheme 1. (R,R)-Me-Duphos 15 gave lower conversion 
and a 6% ee of 7aa (Table 1, entry 18). (R,Sp)-Josiphos 16 and (Rp)-Taniaphos 17 furnished the 
opposite enantiomer ent-endo-7aa in excellent conversions and with 34 and 84% ee, respectively 
(Table 1, entries 19 and 20). The best result obtained at room temperature employing ligand 1713,14 
could not be ameliorated by lowering the reaction temperature to 0 ºC (Table 1, entry 21). In all of 
the examples depicted in Table 1 a total endo-selectivity was observed (1H NMR of the crude 
mixture) except in the reaction promoted by phosphoramidite 14.     
 
 
Scheme 1. Optimization of the enantioselective 1,3-DC of imine 6a with NMM 5a.  
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Figure 1. Ligands tested in the enantioselective 1,3-DC of 6a and NMM 5a.  
 
 
 
Table 1. Optimization of the 1,3-DC of 6a and 5a to yield 7aa. 
Entry Ligand AgX Base Conv. (%)a ee (%)b 
1 (S)-BINAP 4a AgTfa Et3N 100 60 
2 (S)-BINAP 4a AgTfa DIPEA 100 60 
3 (S)-BINAP 4a AgTfa ___ 100 64 
4 (S)-BINAP 4a Ag2CO3 ___ 100 60 
5 (S)-BINAP 4a AgOAc ___ 100 54 
6 (S)-BINAP 4a AgOBz ___ 100 65 
7 (S)-BINAP 4a AgF ___ 100 72 
8 (S)-BINAP 4a AgF ___c 100 62 
9 (S)-Tol-BINAP 4b AgF ___ 100 72 
10 (S)-H8-BINAP 8 AgF ___ 100 50 
11 (S)-Segphos 9 AgF ___ 95 34 
12 (S)-Monophos 10 AgF ___ 100 11 
13 (Sa,R,R)-Phosphoramidite 11a AgF ___ 100 20 
14 (Sa,R,R)-Phosphoramidite 11b AgF ___ 100 26 
15 (Sa,R,R)-H8-Phosphoramidite 12 AgF ___ 100 62 
16 (S)- Phosphoramidite 13 AgF ___ 100 4 
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17 Phosphoramidite 14 AgF ___ 100 60d 
18 (R,R)-Me-Duphos 15 AgF ___ 90 6 
19 (R,Sp)-Josiphos 16 AgF ___ 100 -34e 
20 (Rp)-Taniaphos 17 AgF ___ 100 -84e 
21 (Rp)-Taniaphos 17 AgF ___f 100 -82e 
a
 Determined by 1H NMR of the crude reaction mixture. 
b
 Determined by HPLC using chiral coated columns. Only endo-7a was  
identified by 1H NMR of the crude reaction product. Negative sign means that the opposite enantiomer was obtained. 
c
 Performed at -20 ºC. 
d
 Mixture of endo/exo-diastereoisomers was detected.  
e
 The opposite enantiomer was obtained. 
f
  Performed at 0 ºC. 
 
 
The (Rp)-Taniaphos 17·AgF complex, prepared as previously described, was analyzed by 31P 
NMR and electrospray ionization-mass spectrometry (ESI-MS). In the 31P NMR experiment in 
deuterated chloroform no signals were observed between 25-150 ppm. The same behaviour was 
observed during the analysis of the catalyst generated form (Sa,R,R)-phosphoramidite 11a and 
AgClO4 employed in the study of the enantioselective 1,3-DCs of benzylideneamino esters and 
alkenes.11 Thus, we propose that the normal polymeric character of these nitrogenated complexes is 
favored by π-interaction between an aromatic ring of the ligand and the silver atom.11 In addition, 
acetonitrile/water mixtures employed during the ESI-MS were able to cleave this polymeric 
aggregation finding a molecular ion of m/z 794 corresponding to monomeric 1:1 ligand:silver atom 
species (Rp)-Taniaphos 17·AgF (Figure 2). This disaggregation could also take place by the 
coordination of the freshly generated 1,3-dipole from imino ester 6a to the silver atom, but 31P 
NMR experiment did not clarify this idea.11  
 
   
Figure 2. ESI-MS: m/z 794, [Taniaphos 17·Ag]+.  
 
 
 The scope of the optimized reaction conditions was extended to other different maleimides 5 
and different imino esters 6 (Scheme 2). Imino ester 6a (R2 = H) reacted with N-alkylmaleimides, 
such as NMM (5a) and N-benzylmaleimide (5b) affording endo-cycloadducts 7aa and 7ab, 
respectively. In both cases the isolated purified chemical yield was moderate (45 and 50%) although 
the crude reaction products were pure enough to be used for further transformations is desired. The 
enantioselectivity was 84 and 88% ee in both the crude and purified samples, respectively. N-
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Arylmaleimides 5c-h behave similarly, and NPM (5c) gave the best purified chemical yield (60%) 
of this series, endo-7ac being isolated with a 94% ee. 4-Substituted N-arylmaleimides furnished 
endo-7ad, endo-7ae, and endo-7af in moderate yield (40%, 45%, and 55%, respectively) but the 
enantioselectivities were excellent (90-99% ee). The N-(4-acetylphenyl)maleimide 5d induced the 
best enantioselection of this study (99% ee). N-(3-Chlorophenyl)maleimide 5g gave the 
corresponding product endo-7ag, similar to the results generated from the 4-substituted aryl 
surrogates (45% yield and 88% ee). However, the most sterically hindered N-(2-
methoxyphenyl)maleimide (5h) gave a low yield (48%) of endo-7ah product, but with notable 86% 
ee. Using maleimide 5i as the dipolarophile in the cycloaddition with 6a generated endo-7ai in 45% 
yield and moderate 52% enantioselection. Imino esters 6b and 6c derived from phenylalanine and 
leucine were allowed to react with NMM (5a) obtaining cycloadducts that were much more stable 
to purification conditions. High yields (81% and 95%) and enantioselections (92% and 90% ee) of 
endo-7ba and endo-7ca, respectively, were obtained (Scheme 2). Acrylates, nitrostyrene, α,β-
unsaturated ketones, vinyl sulfones, fumarates, maleic anhydride, benzo- and naphthoquinone, and 
acrylamides were poor dipolarophiles in the reaction, resulting in no or very poor conversions to 
products.  
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Scheme 2. Scope of the enantioselective 1,3-DC of imine 6 and NMM 5a. In brackets are 
represented yields of purified compounds (flash chromatography). 
 
 
 In order to determine the absolute configuration of enantiomerically enriched products 7 
their crystallization was attempted, but the crystals that were obtained were not suitable for X-ray 
diffraction analysis. In this sense, derivatization of molecules 7 was performed using 
methanosulfonyl or benzenesulfonyl chlorides in the presence of a base, but epimerization and some 
unidentified decomposition products were obtained. We therefore assigned the stereochemistry as 
indicated for 7aa in Scheme 1 by analogy to that determined when using chiral BINAP 
4a·AgX8,15,16 or by the chiral phosphoramidite 11a·AgClO411 in the 1,3-DCs between imino esters 
18 and maleimides 5 (Scheme 3). According to the common preference of all these silver(I) 
complexes by the (1S,3R,3aS,6aR) configuration in compounds endo-2 and endo-19 it is reasonable 
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to propose this absolute configuration for the major enantiomer 7aa identified in entries 1-15 of the 
Table 1.           
  
 
Scheme 3. Sterochemical outcome induced by (Sa)-BINAP 4a·silver(I) salts8,15,16 or 
phosphoramidite (Sa,R,R)-11a·AgClO411 in the enantioselective silver-mediated 1,3-DCs of imine 
18 and maleimides 5.  
 
Over the past years, DFT calculations have been shown to be a useful tool for the study of 
the enantioselectivity exhibited in 1,3-DCs catalyzed by chiral silver(I) complexes.10b,11b,17 For that 
reason, we decided to perform a computational exploration of the Gibbs free energy profiles in 
order to analyze the different stereochemical outcomes observed when (S)-BINAP (4a) or (Rp)-
Taniaphos (17) are used as chiral ligands (Table 1, entries 7 and 20). 
In previous work, we demonstrated that the selectivity of the 1,3-DCs using chiral metallic 
complexes arises from the effective blockage of one of the prochiral faces.18 Therefore, we started 
our study analyzing the main geometrical features of the azomethine ylides derived from imine 6a. 
As reported in previous work describing 1,3-DC of azomethine ylides and and maleimides,15b it was 
stated that the fluoride counterion was not considered for calculations because of its long distance 
from the silver cation. Although 19F NMR shifts are not a measure of the naked ness of fluoride19 it 
is possible to use them to establish the relative strength or weakness of the Ag–F bond in the 
presence or absence of ligands. 19F NMR of (Rp)-Taniaphos (17)·AgF in deuterated acetonitrile 
revealed a signal at -100.8 ppm. This result indicated a weaker silver-fluorine bond than the 
corresponding one of pure silver fluoride (-166.3 ppm).19,20 The computed most stable N-metallated 
complexes are gathered in Figure 3. 
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Figure 3. Main geometrical features and relative Gibbs free energies (in kcal mol-1 at 298K) of 
silver complexes derived from imine 6a and (A) (S)-BINAP (4a) or (B) (Rp)-Taniaphos (17) 
computed at B3LYP/6-31G*&LANL2DZ level of theory. Blue surface represents the solvent-
accessible surface with a probe radius of 1.9 Å. 
 
Due to the C2 symmetry of (S)-BINAP, only [(S)-BINAP-Ag]·6a was found as a minimum 
(Figure 3A). In this case, the metallic center is coordinated to the two phosphorous atoms of the 
ligand and to the oxygen of the enolate and the nitrogen atom of the azomethine ylide. This 
coordination pattern leads to the blockage of the (1Re,3Si) prochiral face by the phenyl groups of 
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one phosphine unit, thus prompting the formation of (1S,3R,3aS,6aR)-7aa cycloadducts (Scheme 2). 
On the other hand, when (Rp)-Taniaphos was considered as chiral ligand, two energetically 
accessible N-metallated azomethine ylides are found (Figure 3B). In both ylides, the two 
phosphorous atoms of the ligand are coordinated to the silver atom.21 Therefore, the coordination 
pattern found for both chiral ligands agrees with the absence of signals corresponding to 
uncoordinated aromatic phosphines in the 31P-NMR spectra (vide supra). Noteworthy, with this 
latter chiral ligand, all of the possible metallated complexes effectively block different prochiral 
faces by the diphenylphosphino group attached to the ferrocenyl group. However, the difference in 
energy between them is not enough to assume that only one of them was the real catalytic species in 
solution at room temperature. Therefore, further computational analysis is required for theoretically 
assess the stereochemical outcome.  
We next proceeded to compute the complete profile associated with the 1,3-DCs of NMM 
(5a) and the above-described azomethine ylides. In previous work on 1,3-DCs-assisted by chiral 
Ag-based catalysts we have observed a clear preference for the formation of endo-cycloadducts.22 
This endo preference is consequence of an electrostatic interaction between the nitrogen atom of the 
maleimide and the silver atom. Also a closer distance of one methoxy group of the imino moiety 
and the silver atom exists (dAg-e = 2.73-2.75Å for BINAP 4a complex and dAg-e = 2.76-2.94Å for 
Taniaphos 17 complex, Figure 4) was detected. Therefore, we only have considered the formation 
of cycloadducts endo-7aa and ent-endo-7aa via transition structures TS1 and TS2, respectively.23 
The main geometrical features and relative Gibbs free energies of the least energetic transition 
structures are collected in Figure 4. 
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Figure 4. Main geometrical features and relative Gibbs free energies (in kcal mol-1 at 298K) of 
transition structures associated with the 1,3-DCs of NMM (5a) with silver complexes derived from 
imine 6a and (A) (S)-BINAP (4a) or (B) (Rp)-Taniaphos (17) computed at B3LYP/6-
31G*&LANL2DZ level of theory. Hydrogen atoms of the chiral ligands are omitted for clarity.  
 
 
 Our results show that lowest energy transition states TS1 and TS2 are concerted but quite 
asynchronous, the distance C(3)-C(3a) distance being shorter than its C(1)-C(6a) counterpart (dcd 
and dab in Figure 4 respectively) as in previously reported calculations on similar systems.11b For the 
computed profile for the (S)-BINAP 4a·Ag catalyzed 1,3-DC, TS1 was found to be 0.7 kcal mol-1 
more stable than TS2 (Figure 4A). In the latter transition structure, a higher steric clash between the 
incoming dipolarophile 5a and one phenyl group of (S)-BINAP was found, as expected after 
examination of [(S)-BINAP 4a -Ag]·6a azomethine ylide (vide supra).  
On the contrary, in the computed profile for the (Rp)-Taniaphos·Ag-catalyzed 1,3-DC, TS2 
was found to be 2.4 kcal mol-1 more stable than TS1, thus pointing out to the preferential formation 
of endo-7aa (Figure 4B). In this case the theoretical endo-7aa:ent-endo-7a ratio is obtained of 
1:>99 due to the higher energetic gap between transition structures. Noteworthy, that result is in 
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great agreement with the experimental evidence. Remarkably, each transition structure is related to 
one of the previously computed (Rp)-Taniaphos·6a azomethine ylides, showing the effective 
blockage of the biphenylphosphine moiety attached to the ferrocenyl group advanced by the 
analysis of the initial azomethine ylides.  
 
Finally, the Gibbs energy profiles associated with the computed catalytic cycles were 
computed (Scheme 4). Our results show that the computed activation barriers are low, confirming 
the high conversions and mild conditions described experimentally. Our results show, however, that 
(Rp)-Taniaphos 17·Ag catalytic system present a slightly lower activation barrier associated with 
1,3-DC step compared to (S)-BINAP 4a·Ag. It is observed that the cycloaddition step is 
endothermic in both cases. However, the final step that recovers the catalyst is spontaneous, 
ensuring the recovery of the initial azomethine ylide by release of the final product by coordination 
of fresh imine to the metallic centre. 
  
 
Scheme 4. Gibbs energy profile associated with the formation of cycloadduct 7aa catalyzed by 
silver and (a) (S)-BINAP (4a) or (b) (Rp)-Taniaphos (17) chiral ligand computed at B3LYP/6-
31G*&LANL2DZ level of theory. Energies are in kcal mol-1 and computed at 298 K.  
 
 
3. Conclusions 
The first 1,3-DCs of maleimides and imino esters derived from 2,2-dimethoxyacetaldehyde was 
efficiently accomplished by the chiral catalyst (Rp)-Taniaphos·AgF, which was better than other 
chiral ligands tested under very mild reaction conditions. This catalyst can be defined as 
multifunctional because: a) it activates the dipole with a high control of its geometry; b) it can act as 
base accelerating the reaction; and c) it allows the approach of the maleimide through a weak N-Ag 
interaction. In all cases the reaction was endo-diastereoselective giving rise to 2,5-cis-arrangements 
between two reactive functional groups. Despite problems assigning the absolute configuration, 
experimental results and DFT calculations were used to confirm the proposed stereochemistry of 
endo-cycloadducts. DFT calculations also supported the different enantioselection observed when 
(Rp)-Taniaphos was used as a source of chirality in comparison with the analogous reaction 
mediated by the (S)-BINAP ligand. 
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4. Experimental Part 
 
4.1. General information 
Melting points were determined with a Reichert Thermowar hot plate apparatus and are uncorrected. 
Only the structurally most important peaks of the IR spectra (recorded whit a FT-IR 4100LE (JASCO) 
(PIKE MIRacle ATR) are listed. 1H NMR (300 MHz) 13C NMR (75 MHz) 31P NMR (120 MHz)   and 
spectra were obtained with a Bruker AC-300 by using CDCl3 as solvent and TMS as the internal standard, 
unless otherwise stated. Optical rotations were measured with a Perkin-Elmer 341 polarimeter. HPLC 
analyses were performed with a JASCO-2000 series equipped with a chiral column (detailed for each 
compound in the main text) by using mixtures of n-hexane/isopropyl alcohol as the mobile phase at 25 ºC. 
Low-resolution electron impact (EI) mass spectra were obtained with a Shimadzu QP-5000 by injection or 
DIP, and high-resolution mass spectra were obtained with a Finnigan VG Platform or a Finnigan MAT 95S. 
Analytical TLC was performed on Schleicher & Schuell F1400/LS  254 silica gel plates and the spots were 
visualized under UV light (λ = 254 nm). Merck silica gel 60 (0.040-0.063 mm) was used for flash 
chromatography. 
 
4.2. General procedure for the enantioselective 1,3-DCs. 
In a 10 mL vial covered by aluminum foil, was added AgF (0.63 mg, 0.005 mmol), (Rp)-Taniaphos (3.44 mg, 
0.005 mmol) and toluene (1 mL), and the resulting mixture was stirred at room temperature for 1 h. 
Dimethoxyacetaldehyde imine derivative 6 (0.1 mmol), the corresponding maleimide 5 (0.1 mmol) in 
toluene (2 mL) were added. After 1 d stirring at room temperature the crude was analyzed by 1H NMR 
spectroscopy to determine the diastereomeric ratio, and then purified by column chromatography (flash 
silicagel) eluting with mixtures of hexane and ethyl acetate, affording the product endo-7.  
 
4.3. Methyl (1R,3S,3aR,6aS)-3-(dimethoxymethyl)-5-methyl-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-
1-carboxylate endo-7aa: Sticky pale yellow oil, 15 mg (45%); [α] =	-14.5 (c  0.25, CHCl3), 84% ee from 
HPLC (Daicel Chiralpak OD-H), hexane/i-PrOH 60/40, flow rate 0.8 mL/min, tRmin: 25.6 min, tRmaj: 31.5 
min, 254 nm; IR νmax: 3648, 1747, 1697 cm-1;  1H-NMR δ: 2.14 (br. s, 1H, NH), 2.96 (s, 3H, MeN), 3.32 (t, J 
= 7.8 Hz, 1H, CHCHCHCON), 3.42 (s, 3H, CHOMe), 3.44-3.54 (m, 2H, CHCHCO2Me, CHCHO2), 3.55 (s, 
3H, CHOMe), 3.84 (s, 3H, CO2Me), 3.98 (d, J = 7.8 Hz, 1H, CHCO2Me), 4.70 (d, J = 4.6 Hz, 1H, CHO2); 
13C-NMR δ: 25.2 (NCH3), 46.4, 49.1 (2xCHCON), 52.5 (CO2Me), 55.8, 56.0 (2xCOMe), 62.1 (CHCO2Me), 
63.4 (CHCHO2), 102.7 (CHO2), 170.0, 175.7, 175.8 (3xCO); MS m/z (%): 286 (M+ 1%), 211 (16), 195 (30), 
165 (22), 151 (15), 94 (18), 75 (100); HRMS calculated for (C12H18N2O6): 286.1165, found: 286.1158. 
 
4.4. Methyl (1R,3S,3aR,6aS)-5-benzyl-3-(dimethoxymethyl)-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-
1-carboxylate endo-7ab: Sticky colourless oil, 18 mg (50%); [α] =	-23.8 (c  1.18, CHCl3), 88% ee from 
HPLC (Daicel Chiralpak IA), hexane/i-PrOH 90/10, flow rate 1 mL/min, tRmaj: 23.1 min, tRmin: 24.9 min, 254 
nm; IR νmax: 3656, 1747, 1700 cm-1; 1H-NMR δ: 2.10 (br. s, 1H, NH); 3.17 (s, 3H, CHOMe), 3.31 (dd, J = 
8.3, 2.8, 1H, CHCHCHCON), 3.49 (s, 3H, CHOMe), 3.72-3.80 (m, 2H, CHCHCO2Me, CHCHO2), 3.83 (s, 
3H, CO2Me), 3.99 (d, J = 7.7 Hz, 1H, CHCO2Me), 4.55 (d, J = 14.3 Hz, 1H, CH2), 4.65-4.73 (m, 2H, 1H 
CH2, CHO2), 7.29-7.38 (m, 5H, ArH); 13C-NMR δ: 42.9 (CH2), 46.6, 49.3 (2xCHCON), 52.6 (CO2Me), 55.6, 
55.8 (2xCOMe),  62.4 (CHCO2Me), 63.7 (CHCHO2), 102.0 (CHO2),  128.0, 128.6, 128.7, 135.5 (ArC), 
169.6, 175.2, 175.3 (3xCO); MS m/z (%): 362 (M+ 1%), 300 (15), 287 (20), 271 (17), 241 (19), 227 (15), 91 
(35), 75 (100); HRMS calculated for (C18H22N2O6): 362.1478, found: 362.1465. 
 
4.5. Methyl (1R,3S,3aR,6aS)-3-(dimethoxymethyl)-4,6-dioxo-5-phenyloctahydropyrrolo[3,4-c]pyrrole-
1-carboxylate endo-7ac: Sticky colourless oil, 21 mg (60%);  [α] =	-33.1 (c  0.86, CHCl3), 94% ee from 
HPLC (Daicel Chiralpak OD-H), hexane/i-PrOH 60/40, flow rate 0.8 mL/min, tRmaj: 24.9 min, tRmin: 31.7 
min, 254 nm; IR νmax: 3748, 1746, 1705 cm-1; 1H-NMR δ: 2.13 (br. s, 1H, NH); 3.40 (s, 3H, CHOMe), 3.44-
3.50 (m, 2H, CHCHCHCON, CHCHO2), 3.55 (s, 3H, CHOMe), 3.68 (t, J = 7.8 Hz, 1H, CHCHCO2Me), 
3.83 (s, 3H, CHOMe), 4.12 (d, J = 7.8 Hz, 1H, CHCO2Me), 4.80 (d, J = 3.7 Hz, 1H, CHO2), 7.21-7.26 (m, 
2H, ArH), 7.35-7.50 (m, 3H, ArH); 13C-NMR δ: 46.9, 49.4 (2xCHCON), 52.7 (CO2Me), 56.0, 56.1 
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(2xCOMe), 62.6 (CHCO2Me), 64.0 (CHCHO2), 102.1 (CHO2), 126.7, 129.0, 129.3, 131.8 (ArC), 169.8, 
174.7, 174.8 (3xCO); MS (EI) m/z (%): 348 (M+ 1%), 286 (15), 273 (16), 257 (22), 227 (30), 94 (19), 75 
(100); HRMS calculated for (C17H20N2O6-C3H7O2): 273.0875, found: 273.0873. 
 
4.6. Methyl (1R,3S,3aR,6aS)-5-(4-acetylphenyl)-3-(dimethoxymethyl)-4,6-dioxooctahydropyrrolo[3,4-
c]pyrrole-1-carboxylate endo-7ad: Colourless oil, 16 mg (40%);  [α] =	-26.3 (c  0.49, CHCl3), 99% ee 
from HPLC (Daicel Chiralpak ADH), hexane/i-PrOH 90/10, flow rate 1 mL/min, tRmaj: 17.7 min, tRmin: 21.8 
min, 254 nm; IR νmax: 3674, 1743, 1703, 1683 cm-1; 1H-NMR δ: 2.62 (s, 3H, MeC=O), 3.10 (br. s, 1H, NH); 
3.39 (s, 3H, CHOMe), 3.42-3.49 (m, 1H, CHCHCHCON), 3.55 (s, 3H, CHOMe), 3.64 (dd, J = 8.3, 3.5 Hz, 
1H, CHCHO2), 3.72 (td, J = 7.5, 4.5, 1H, CHCHCO2Me), 3.84 (s, 3H, OMe), 4,13 (d, J = 7.5, 1H,  
CHCO2Me), 4.79 (d, J = 3.5 Hz, 1H, CHO2), 7.40, 8,05 (2xd, J = 8.3 Hz, 4H, ArH); 13C-NMR δ: 26.8 
(MeC=O), 46.8, 49.4 (2xCHCON), 52.8 (CO2Me), 55.9, 56.0 (2xCOMe), 62.5 (CHCO2Me), 63.9 
(CHCHO2), 102.0 (CHO2), 126.6, 129.3, 135.8, 137.0 (ArC), 169.9, 174.2, 174.2 (3xCO), 197.1 (MeC=O); 
MS (EI) m/z (%): 390 (M+ 1%), 299 (8), 146 (5), 126 (4), 94 (8), 84 (5), 75 (100), 68 (5); HRMS calculated 
for (C19H22N2O7-C3H7O2): 315.0981, found: 315.0965. 
 
 
Methyl (1R,3S,3aR,6aS)-5-(4-chlorophenyl)-3-(dimethoxymethyl)-4,6-dioxooctahydropyrrolo[3,4-
c]pyrrole-1-carboxylate endo-7ae: Pale yellow oil, 18 mg (45%);  [α] =	-50.1 (c  0.66, CHCl3), 90% ee 
from HPLC (Daicel Chiralpak ODH), hexane/i-PrOH 60/40, flow rate 0.8 mL/min, tRmaj: 27.8 min, tRmin: 35.3 
min, 254 nm; IR νmax: 3675, 1746, 1707 cm-1; 1H-NMR δ: 2.65 (br. s, 1H, NH); 3.39 (s, 3H, CHOMe), 3.44-
3.51 (m, 1H, CHCHCHCON), 3.54 (s, 3H, CHOMe), 3.60 (dd, J = 8.3, 4.10 Hz, 1H, CHCHO2), 3.69 (t, J = 
7.8, 1H, CHCHCO2Me), 3.83 (s, 3H, CO2Me), 4.07 (d, J = 7.8 Hz, 1H, CHCO2Me), 4.77 (d, J = 4.0 Hz, 1H, 
CHO2), 7.21, 7.43 (2xd, J = 8.9 Hz, 4H, ArH); 13C-NMR δ: 46.8, 49.4 (2xCHCON), 52.7 (CO2Me), 55.9, 
56.0 (2xCOMe), 62.6 (CHCO2Me), 64.0 (CHCHO2), 102.1 (CHO2), 127.9, 129.5, 130.2, 134.8 (ArC),  
169.8, 174.5, 174.5 (3xCO); MS (EI) m/z (%): 382 (M+ 1%), 320 (15), 291 (15), 261 (36), 153 (14), 94 (14), 
75 (100); HRMS calculated for (C17H19ClN2O6-ClC6H4): 271.0930, found: 271.0939. 
 
Methyl (1R,3S,3aR,6aS)-5-(4-bromophenyl)-3-(dimethoxymethyl)-4,6-dioxooctahydropyrrolo[3,4-
c]pyrrole-1-carboxylate endo-7af: Colourless oil, 23 mg (53%); [α] =	-44.7 (c  0.98, CHCl3), 90% ee, 
from HPLC (Daicel Chiralpak ODH), hexane/i-PrOH 60/40, flow rate 0.8 mL/min, tRmaj: 29.8 min, tRmin: 36.9 
min, 254 nm; IR νmax: 3656, 1752, 1710 cm-1; H-NMR δ: 3.38 (s, 3H, CHOMe), 3.43-3.51 (m, 2H, NH, 
CHCHCHCON), 3.54 (s, 3H, CHOMe), 3.59-3.61 (m, 1H, CHCHO2), 3.67-3.79 (m, 1H, CHCHCO2Me), 
3.83 (s, 3H, CO2Me), 4.10 (d, J = 7.8 Hz, 1H, CHCO2Me), 4.78 (d, J = 3.9 Hz, 1H, CHO2), 7.15 (d, J = 8.8 
Hz, 2H, ArH), 7.59 (d, J = 8.8 Hz, 2H, ArH); 13C-NMR δ: 46.8, 49.3 (2xCHCON), 52.8 (CO2Me), 55.9, 56.0 
(2xCOMe), 62.6 (CHCO2Me), 63.9 (CHCHO2), 102.0 (CHO2), 122.8, 128.2, 130.6, 132.5 (ArC), 169.7, 
174.4, 174.5 (3xCO); EM (IE) m/z (%):427 (M+ 1%), 395 (5), 335 (7), 307 (7), 197 (6), 110 (5), 94 (13%), 
75 (100); HRMS calculated for (C17H19BrN2O6-C3H7O2): 350.9980, found: 350.9979. 
 
 
Methyl (1R,3S,3aR,6aS)-5-(3-chlorophenyl)-3-(dimethoxymethyl)-4,6-dioxooctahydropyrrolo[3,4-
c]pyrrole-1-carboxylate endo-7ag: Pale yellow oil, 18 mg (45%); [α] =	-48.4 (c  0.62, CHCl3) 88% ee, 
from HPLC (Daicel Chiralpak ODH), hexane/i-PrOH 60/40, flow rate 0.8 mL/min, tRmaj: 23.8 min, tRmin: 30.1 
min, 254 nm; IR νmax: 3675, 1746, 1713 cm-1; 1H-NMR δ: 3.41 (s, 3H, CHOMe), 3.44-3.51 (m, 2H, NH, 
CHCHCHCON), 3.55 (s, 3H, CHOMe), 3.68-3.81 (m, 2H, CHCHCO2Me, CHCHO2), 3.85 (s, 3H, CO2Me), 
4.17 (d, J = 7.8 Hz, 1H, CHCO2Me), 4.80 (d, J = 3.8 Hz, 1H, CHO2), 7.15-7.20 (m, 1H, ArH), 7.28-7.30 (m, 
1H, ArH), 7.35-7.45 (m, 2H, ArH); 13C-NMR δ: 46.7, 49.3 (2xCHCON), 52.9 (CO2Me), 56.1, 56.2 
(2xCOMe), 62.4 (CHCO2Me), 63.8 (CHCHO2), 101.8 (CHO2), 124.8, 126.9, 129.2, 130.3, 132.8, 134.8 
(ArC), 169.4, 174.1, 174.2 (3xCO); MS (EI) m/z (%): 382 (M+ 1%), 320 (15), 291 (13), 261 (28), 153 (10), 
94 (15), 75 (100); HRMS calculated for (C17H19ClN2O6-C3H7O2): 307.0486, found: 307.0479. 
 
 
Methyl (1R,3S,3aR,6aS)-3-(dimethoxymethyl)-5-(2-methoxyphenyl)-4,6-dioxooctahydropyrrolo[3,4-
c]pyrrole-1-carboxylate endo-7ah: Pale yellow oil, 10 mg (25%); [α] =	-18.4 (c  0.36, CHCl3) 86% ee, 
from HPLC (Daicel Chiralpak ODH), hexane/i-PrOH 60/40, flow rate 0.8 mL/min, tRmaj: 23.1 min, tRmin: 36.7 
min, 254 nm; IR νmax: 3751, 1746, 1709 cm-1; 1H-NMR δ: 3.34 (s, 3H, CHOMe min); 3.43 (s, 3H, CHOMe); 
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3.44-3.50 (m, 6H,  NH, CHCHCHCON, CHCHCO2Me), 3.52 (s, 3H, CHOMemin), 3.55 (s, 3H, CHOMe), 
3.66-3.77 (m, 2H, CHCHO2), 3.78 (s, 3H, CHOMe), 3.81 (s, 3H, ArOMemin, ArOMe), 3.82 (s, 3H, CO2Me), 
3.86 (s, 3H, CO2Memin), 4.16 (t, J = 7.2 Hz, 1H, CHCO2Me), 4.75 (d, J = 4.4 Hz, 1Hmin, CHO2), 4.83 (d, J = 
3.8, 1H, CHO2), 6.97-7.05 (m, 4H, ArH), 7.11 (ddd, J = 8.0, 6.2, 1.7, 2H, ArH), 7.36-7.42 (m, 2H, ArH); 
13C-NMR δ: 46.9, 47.3, 49.4, 49.5 (4xCHCON), 52.6, 52.8, 55.2, 55.8, 55.9, 56.0 (6xOMe), 62.3, 62.7 
(2xCHCO2Me), 63.6, 63.8 (2xCHCHO2), 101.8, 101.9 (2xCHO2), 112.1, 112.3, 120.4, 120.7, 120.9, 121.1, 
129.0, 129.4, 130.9, 131.2, 154.3, 154.7 (ArC), 169.1, 161.2, 169.5, 174.2, 174.3, 174.4 (6xCO); MS (EI) 
m/z (%): 378 (M+ 1%), 346 (15), 315 (17), 303 (62), 287 (31), 257 (15), 149 (21), 110 (16), 94 (38), 75 
(100); HRMS calculated for (C18H22N2O7): 378.1427, found: 378.1423. 
 
 
Methyl (1R,3S,3aR,6aS)-3-(dimethoxymethyl)-4,6-dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate 
endo-7ai: Pale yellow oil, 14 mg (45%); [α] =	-17.8 (c  0.35, CHCl3) 52% ee, from HPLC (Daicel 
Chiralpak ODH), hexane/i-PrOH 60/40, flow rate 0.8 mL/min, tRmin: 18.2 min, tRmaj: 23.2 min, 254 nm; IR 
νmax: 3800-3650, 1740, 1709 cm-1; 1H-NMR δ: 1.75-2.5 (br. S, 2H, 2xNH), 3.34 (t, J = 8.0 Hz, 1H, 
CHCHCHCON), 3.44 (s, 3H, CHOMe), 3.48 (dd, J = 9.1, 4.7 Hz, 1H, CHCHO2), 3.54 (s, 3H, CHOMe), 
3.58 (t, J = 8.0, Hz, 1H, CHCHCO2Me), 3.83 (s, 3H, CO2Me), 3.97 (d, J = 7.9 Hz, 1H, CHCO2Me), 4.71 (d, 
J = 4.7 Hz, 1H, CHO2); 13C-NMR δ: 47.5, 50.1 (2xCHCON), 52.8, 55.9 (2xCHOMe), 56.1 (CO2Me), 61.9 
(CHCO2Me), 63.3 (CHCHO2), 102.2 (CHO2), 169.1, 174.9, 175.0 (3xCO); MS (EI) m/z (%): 272 (M+ 1%), 
241 (15), 181 (24), 151 (18), 94 (14), 75 (100); HRMS calculated for (C11H16N2O6-C3H7O2): 197.0562, 
found: 197.0570. 
 
 
Methyl (1R,3S,3aR,6aS)-1-benzyl-3-(dimethoxymethyl)-5-methyl-4,6-dioxooctahydropyrrolo[3,4-
c]pyrrole-1-carboxylate endo-7ba: Pale yellow oil, 32 mg (81%);  [α] =	-21.4 (c  1.43, CHCl3) 92% ee, 
from HPLC (Daicel Chiralpak ODH), hexane/i-PrOH 95/5, flow rate 1 mL/min, tRmaj: 34.1 min, tRmin: 39.4 
min, 254 nm; IR νmax: 3659, 1726, 1698 cm-1; 1H-NMR δ: 1.34 (t, J = 7.2 Hz, 3H, CCH3), 2.93 (s, 3H, MeN), 
3.02 (br. s, Hz, 1H, NH), 3.27-3.46 (m with s at 3.35, 7H, 2xCHCON, CH2Ph, OMe), 3.49 (s, 3H, OMe), 
3.71 (dd, J = 8.5, 3.5 Hz, 1H, CHCHO2), 4.27 (qd, J = 7.1, 1.0 Hz, 2H, CH2Me), 4.67 (d, J = 3.9 Hz, 1H, 
CHO2), 7.27 (m, 5H, ArH); 13C-NMR δ: 14.2 (CH2CH3), 25.2 (NCH3), 40.9 (CH2Ar), 47.0, 55.0 
(2xCHCON), 55.7, 55.7 (2xCHOMe), 61.5 (CHCO2Me), 62.0  (CHCHO2), 72.2 (CCH2Ph), 102.1 (CHO2), 
127.3, 128.5, 130.2, 135.7 (ArC), 170.6, 175.3, 175.8 (3xCO); MS (EI) m/z (%): 390 (M+ 1%), 315 (24), 299 
(24), 285 (22), 267 (100), 237 (13), 91 (34), 75 (23); HRMS calculated for (C20H26N2O6-C3H7O2): 315.1345, 
found: 315.1347. 
 
 
Methyl (1R,3S,3aR,6aS)-1-(2-methylpropyl)-3-(dimethoxymethyl)-5-methyl-4,6-
dioxooctahydropyrrolo[3,4-c]pyrrole-1-carboxylate endo-7ca: Colourless sticky oil, 34 mg (95%);   
[α]
 =	-18.5 (c  1.33, CHCl3) 90% ee, from HPLC (Daicel Chiralpak IA), hexane/EtOH 90/10, flow rate 1 
mL/min, tRmin: 11.8 min, tRmaj: 18.5 min, 254 nm; IR νmax: 3820-3650, 1734, 1698 cm-1; 1H-NMR δ: 0.83, 
0.95 (2xd, J = 6.7 Hz, 6H, CHMe2), 1.48 (dd, J = 14.2, 5.0 Hz, 1H, CH2), 1.66-1.82 (m, 1H, CHMe2), 1.99 
(dd, 1H, J = 14.2, 9.0 Hz), 2.91 (s, 3H, NMe), 2.95 (br. s, Hz, 1H, NH), 3.12 (d, J = 7.6 Hz, 1H, 
CHCCO2Me), 3,29 (dd, J = 7.6, 7.5 Hz, 1H, CHCHCHCON), 3.35, 3.47 (2xs, 6H, 2xCHOMe), 3.53 (dd, J = 
7,5, 2.5 Hz, 1H, CHCHO2), 3.83 (s, 3H, CO2Me), 4.78 (d, J = 2.5 Hz, 1H, CHO2); 13C-NMR δ: 22.3, 24.2 
(CHMe2), 24.9 (CH2), 25.1 (NCH3), 43.7 (CHMe2), 47.7, 52.5 (2xCHCON), 54.5, 55.7 (2xCHOMe), 57.3, 
62.2, 71.4 (CCH2CH), 100.9 (CHO2), 172.5, 175.6, 176.2 (3xCO); MS (EI) m/z (%): 342 (M+ 1%), 283 (35), 
268 (15), 267 (100), 253 (15), 251 (24), 207 (43), 165 (25), 75 (89); HRMS calculated for (C16H26N2O6-
C3H7O2): 267.1345, found: 267.1349. 
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